Overview

This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam Treatmen

Status:
Completed

Trial end date:
2017-09-01

Target enrollment:

Participant gender:

Summary

This trial, evaluating the long-term safety and tolerability of brivaracetam will provide subjects suffering from epilepsy, who may have benefited from brivaracetam as adjunctive treatment, the opportunity to receive open label brivaracetam treatment.

Phase:

Phase 3

Details

Lead Sponsor:

UCB PHARMA Inc. (US)

Treatments:

Brivaracetam